4processed
Form 4 — Insider Transaction
KalVista Pharmaceuticals, Inc.(KALV)
Filing Date
June 11, 2026
Accepted
June 11, 2026
Accession No.
0001860131-26-000010
CIK
0001348911
Insider Transactions
| Insider | Title | Type | Shares | Price | Value | Owned After | Security | Date |
|---|---|---|---|---|---|---|---|---|
| Audhya Paul K. | CHIEF MEDICAL OFFICER | Other | 150.3K | $0 | — | 0 | Common Stock | Jun 11, 2026 |
| Audhya Paul K. | CHIEF MEDICAL OFFICER | Other | 100.0K | — | — | 0 | Stock Option (Right to Buy) | Jun 11, 2026 |
| Audhya Paul K. | CHIEF MEDICAL OFFICER | Other | 25.8K | — | — | 0 | Stock Option (Right to Buy) | Jun 11, 2026 |
| Audhya Paul K. | CHIEF MEDICAL OFFICER | Other | 40.0K | — | — | 0 | Restricted Stock Unit | Jun 11, 2026 |
| Audhya Paul K. | CHIEF MEDICAL OFFICER | Other | 68.8K | — | — | 0 | Restricted Stock Unit | Jun 11, 2026 |
| Audhya Paul K. | CHIEF MEDICAL OFFICER | Other | 93.8K | — | — | 0 | Restricted Stock Unit | Jun 11, 2026 |